Madelyn Frank

University of California, Irvine

Papers

2

Total Citations

18

H-Index

2

About

Dr. Madelyn Frank is a rising surgical oncologist whose research focuses on optimizing outcomes for patients with thoracic and head and neck cancers. Her work critically examines the interplay between modern treatment protocols and surgical timing. In her highly cited 2023 systematic review, Dr. Frank evaluated short-term outcomes of minimally invasive thoracoscopic surgery for lung cancer following neoadjuvant systemic therapy, a key area where evidence is rapidly evolving. This work, which has already garnered 15 citations, helps clarify the safety and efficacy of video-assisted and robotic-assisted thoracoscopic surgeries in this complex patient population. More recently, Dr. Frank has turned her analytical lens to oropharyngeal squamous cell carcinoma. Her 2024 study, leveraging the National Cancer Database, investigates the critical relationship between treatment delay and survival, stratified by HPV status, in patients undergoing upfront surgery. By dissecting these nuanced variables, her research provides actionable insights for clinical decision-making. Dr. Frank’s contributions are establishing her as a thoughtful voice in evidence-based surgical oncology, bridging the gap between clinical data and improved patient care.

Research Focus

Key Achievements

2
H-Index
2
Papers
18
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
A Systematic Review of Short-Term Outcomes of Minimally Invasive Thoracoscopic Surgery for Lung Cancer after Neoadjuvant Systemic Therapy
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of California, Irvine

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago